Cytokeratin 20‐positive large cell neuroendocrine carcinoma of the colon
Authors:
- 5 July 2005
- journal article
- case report
- Published by Wiley in Pathology International
- Vol. 55 (8) , 524-529
Abstract
Herein is presented a case of cytokeratin (CK) 20‐positive large cell neuroendocrine carcinoma of the colon, in which the tumor was clinically at stage IV and located in the ascending colon. Pathological examination of the resected tumor revealed nested and solid proliferation of large undifferentiated cells with vesicular nucleus and prominent nucleoli. No areas showed differentiation toward adenocarcinoma or squamous cell carcinoma. Tumor cells were immunohistochemically positive for chromogranin A, synaptophysin, CD 56 (focal), and bore electron‐dense granules. With these features, the tumor was diagnosed as a large cell neuroendocrine carcinoma of the colon. Liver metastasis and local recurrence progressed, and the patient died of the primary disease 7 months after operation. The autopsy confirmed this diagnosis without detectable tumors in the lungs. Interestingly, more than half of the tumor cells were positive for CK 20, while CK 7 was not expressed. Most neuroendocrine carcinomas do not express CK 20, with the exception of Merkel cell carcinomas, and most colorectal adenocarcinomas express CK 20. To the best of the authors’ knowledge, the present case is the first CK 20‐positive, CK 7‐negative colorectal neuroendocrine carcinoma to be described, suggesting a link between colorectal neuroendocrine carcinoma and conventional adenocarcinoma.Keywords
This publication has 15 references indexed in Scilit:
- Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tractHistopathology, 2003
- Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumorsHuman Pathology, 2001
- Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesLaboratory Investigation, 2000
- Concordance of Genetic Alterations in Poorly Differentiated Colorectal Neuroendocrine Carcinomas and Associated AdenocarcinomasJNCI: Journal of the National Cancer Institute, 1997
- Cytokeratin 20 Immunoreactivity Distinguishes Merkel Cell (Primary Cutaneous Neuroendocrine) Carcinomas and Salivary Gland Small Cell Carcinomas from Small Cell Carcinomas of Various SitesAmerican Journal of Surgical Pathology, 1997
- The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomasDifferentiation, 1993
- Neuroendocrine Tumors of the Lung With Proposed Criteria for Large-Cell Neuroendocrine CarcinomaAmerican Journal of Surgical Pathology, 1991
- Neuroendocrine Carcinoma of the Colon and Rectum A Clinicopathologic, Ultrastructural, and Immunohistochemical Study of 24 CasesAmerican Journal of Surgical Pathology, 1990
- Small-cell undifferentiated carcinoma of the colonAmerican Journal of Surgical Pathology, 1983
- Neuroendocrine carcinomas of the colonAmerican Journal of Surgical Pathology, 1978